Themis Medicare Reports Q1 Net Loss of 142 Million Rupees Amid Revenue Decline
Themis Medicare, a pharmaceutical company, reported a consolidated net loss of ₹142.00 million in Q1, contrasting with a ₹247.00 million profit in the same quarter last year. Revenue decreased by 24.92% to ₹976.00 million from ₹1,300.00 million. EBITDA turned negative at ₹101.00 million loss, compared to a positive ₹292.00 million in the previous year's quarter.
20May 25
Themis Medicare Reports Q4 Revenue Decline and Net Loss
Themis Medicare's Q4 financial results show a significant downturn. The company reported a net loss of ₹96.60 million, contrasting with a profit of ₹66.40 million in the same quarter last year. Revenue decreased by 26.70% compared to the previous quarter. This marks a notable shift from the ₹5.20 million profit in the preceding quarter, indicating volatility in the company's financial performance.